Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prompt Panretinal Photocoagulation Versus Intravitreal Ranibizumab With Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

NCT01489189 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT01489189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01489189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prompt Panretinal Photocoagulation Versus Intravitreal Ranibizumab With Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
February 5, 2018
Enrollment
305 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy